2:33 PM
 | 
Feb 27, 2018
 |  BC Extra  |  Company News

Management tracks: Sotio, EpimAb

Cancer and autoimmune disease company Sotio a.s. (Prague, Czech Republic) said CEO Ladislav Bartonícek will transition to the company's board, effective March 1. He is succeeded by CSO and Co-founder Radek Spíšek.

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >